Barely Significant
← all phrases

“showed a trend”

53,323 sentences · 53,323 papers · 65,371 search hits before verification

In the literature

showed a trendp=.081.6× alpha
Relationship Between BMI and Dietary Added Sugar on Circulating GLP-1 Simple regressions showed a trend towards a negative correlation between BMI and circulating GLP-1 (AUC) (β=-.21, p=.08), but no significant correlation between percent calories from added sugar and circulating GLP-1 (AUC) (β=.09, p=.49) following a glucose drink.
showed a trendp = 0.081.6× alpha
With regard to the PSQI sub-scores (not presented), only sleep onset latency showed a trend of being shorter with the DP as compared to the placebo (modPP, p = 0.08, effect difference: 15%, 95% CI: −1.5–30.3%).
showed a trendP = 0.081.6× alpha
Pairwise comparisons showed a trend for a significant decrease in plasma glucose concentration with exercise in the non-obese subject group (81.6 ± 2.8 versus 76.1 ± 4.0; P = 0.08), but not within the group of subjects with obesity (83.8 ± 2.2 versus 81.6 ± 3.3; P = 0.46).
showed a trendp = 0.0801.6× alpha
In the righting reflex test, the two-way repeated-measures ANOVA showed a trend toward an effect of picrotoxin treatment [ F (1, 42) = 3.216, p = 0.080], no picrotoxin treatment × day of testing interaction [ F (2, 84) = 1.415, p = 0.249; n = 18 control mice, n = 26 picrotoxin-exposed mice; Figure 2B ], and a significant effect of day of testing [ F (1.424, 59.80) = 39.04, p < 0.0001].
showed a trendP value = 0.081.6× alpha
This showed a trend for increased maintenance of expanded pre-existing clones in responders ( P value = 0.08). 56 In other tumour types, Valpione et al. analysed pre-treatment biopsies from 20 patients with metastatic melanoma undergoing anti-PD-1 treatment. 57 They found higher TCR clonality pre-treatment in patients responding to ICB.
TCR sequencing: applications in immuno-oncology research.
Immunooncol Technol · 2023 · PMC9996383
showed a trendp = 0.081.6× alpha
Attaining the quasi-optimal/suboptimal joint PK/PD target of CI piperacillin–tazobactam showed a trend toward a higher risk of microbiological failure (33.3% vs. 0.0%; p = 0.08) (4) Conclusions: Real-time TDM-guided optimal joint PK/PD target attainment of CI piperacillin–tazobactam monotherapy may represent a valuable and effective carbapenem-sparing strategy when dealing with non-severe ESBL-producing Enterobacterales secondary BSIs.